Advanced Non-Invasive Diagnostics in Inflammatory Bowel Disease
ANDI
A Comparative Study of the Diagnostic Validity of Ultrasound, Magnetic Resonance Imaging and Capsule Endoscopy of Both the Small and Large Intestine in Suspected Crohn's Disease
1 other identifier
interventional
153
1 country
3
Brief Summary
The purpose of this study is to determine whether Non-invasive endoscopic procedures (pillcam colon capsule endoscopy, PCCE) and non-ionizing radiological modalities (MR enterocolonography, MREC and ultrasound, US) - offer a sufficiently high diagnostic validity in patients with suspected CD compared to the traditional invasive approach using ileocolonoscopy with biopsies as first line diagnostic modality
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2016
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 6, 2017
CompletedFirst Posted
Study publicly available on registry
May 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2020
CompletedNovember 1, 2022
October 1, 2022
4.3 years
January 6, 2017
October 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Sensitivity and specificity of PCCE, MREC and US for the diagnosis of CD
Sensitivity and specificity of PCCE, MREC and US for the diagnosis of CD located in the terminal ileum and colon (per patient \& per segment). Ileocolonoscopy serves as gold standard
36 months
Correlation of disease severity
Correlation of disease severity assessed with PCCE, MREC, US and ileocolonoscopy
36 months
Inter-observer agreement
Inter-observer agreement with PCCE, MREC, US and ileocolonoscopy
36 months
Secondary Outcomes (4)
Diagnostic yield of proximal CD
36 months
Patients reported experience
36 months
Interobserver PCCE
36 months
Utility of diffusion weighed magnetic resonance imaging (dw-MREC) and US Doppler flow
36 months
Study Arms (1)
trial participant
OTHERAll participants undergoes the same diagnostic imaging
Interventions
Eligibility Criteria
You may qualify if:
- General criterion
- All of the following:
- Clinical suspicion of CD
- Age \> 15 years
- Negative serologic markers for celiac disease, negative stool culture (or polymerase chain reaction) for pathogenic bacteria and a negative microscopy for intestinal parasites
- Fecal calprotectin \> 50 mg/kg
- Signed informed consent
- Clinical criterion Diarrhea and/or abdominal pain for more than 1 month (or repeated episodes of diarrhea and/or abdominal pain) associated with one or more of the following findings: (1) C-reactive protein (CRP) \>5 mg/L, (2) thrombocytosis (\> 400 x 109/L), anemia (hemoglobin \< 7.0 mmol/L for women and \< 8.0 mmol /L for men or a decrease \> 0.5 mmol/L compared to the usual level), (3) prolonged fever (\> 37.5 C for more than 2 weeks), (5) weight loss (≥ 3 kg or ≥ 5% compared to the normal body weight), (6) perianal abscess/fistula, or (7) a family history of inflammatory bowel disease.
You may not qualify if:
- Acute bowel obstruction
- Pregnancy or lactation
- Alcohol or drug abuse
- Known gastrointestinal disorder other than inflammatory bowel disease
- Renal failure defined by a plasma-creatinine above the normal reference range
- Claustrophobia, cardiac pacemaker or implanted magnetic foreign bodies that precludes MREC
- Interpreter required or inability to understand the oral and written information
- Colonoscopy contraindicated, performed within 3 months or unwillingness to go through colonoscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Esbjerg Hospital - University Hospital of Southern Denmarklead
- Odense University Hospitalcollaborator
- Sygehus Lillebaeltcollaborator
Study Sites (3)
Sydvestjysk sygehus
Esbjerg, DK-6700, Denmark
Odense university Hospital
Odense, DK-5000, Denmark
Sygehus Lillebaelt
Vejle, DK-7100, Denmark
Related Publications (2)
Brodersen JB, Jensen MD, Juel MA, Kjeldsen J, Knudsen T, Rafaelsen SR. Intestinal ultrasound in patients with suspected Crohn's disease - results of a prospective evaluation by trainees. Scand J Gastroenterol. 2023 Jul-Dec;58(12):1405-1411. doi: 10.1080/00365521.2023.2234538. Epub 2023 Jul 17.
PMID: 37459054DERIVEDBrodersen JB, Knudsen T, Kjeldsen J, Juel MA, Rafaelsen SR, Jensen MD. Diagnostic accuracy of pan-enteric capsule endoscopy and magnetic resonance enterocolonography in suspected Crohn's disease. United European Gastroenterol J. 2022 Nov;10(9):973-982. doi: 10.1002/ueg2.12307. Epub 2022 Sep 7.
PMID: 36069336DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jacob B Brodersen, MD
Esbjerg Hospital - University Hospital of Southern Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist Registrat
Study Record Dates
First Submitted
January 6, 2017
First Posted
May 1, 2017
Study Start
June 1, 2016
Primary Completion
August 31, 2020
Study Completion
October 23, 2020
Last Updated
November 1, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share